# Glenmark Pharmaceuticals Inc  USA – FDA Inspection, May 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/51543d47-6df2-4fe4-897e-2dd19b3aca7a
Source feed: FDA_Inspections

> FDA inspection 1052635 of Glenmark Pharmaceuticals Inc  USA, May 18, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1052635
- Company Name: Glenmark Pharmaceuticals Inc  USA
- Inspection Date: 2018-05-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Atlanta District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1267093 - 2025-06-17](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/3ab7d010-f073-47f9-8788-ab4b11e320be)
- [FDA Inspection 1169876 - 2022-05-19](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/c6d894dc-2cf7-4a92-a7a4-e3bc286496af)
- [FDA Inspection 1097806 - 2019-07-26](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/1590af97-9645-4c46-b18b-24ab434e394f)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jared-p-stevens/11cd48ff-e61f-4448-98be-efe2f8377fc1)
- Issuing Officer
- [Issuing Officer](https://www.keypedia.com/people/vincent-thomas/0925480c-5d8c-411f-86ee-5e4b924f8c12)

Company: https://www.keypedia.com/companies/glenmark-pharmaceuticals-inc-usa/83c18d68-8e9d-454a-a365-3fe29c7d3e31

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7